Current Neuropharmacology


Ferdinando Nicoletti
Department of Pharmaceutical Sciences
University Rome"da Sapienza"

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 16 Issue: 5, June 2018

Meet Our Editorial Board Member free to download

Volume:16   Issue: 5
Pp: 505-505
J.C. Arnold
DOI: 10.2174/1570159X1605180510145314
Published on: 10 May, 2018

Editorial: Glia-Neuron Crosstalk and its Therapeutic Implication in Neuropsychiatric Disorders free to download

Volume:16   Issue: 5
Pp: 506-507
Yong-Ku Kim
DOI: 10.2174/1570159X1605180510145459
Published on: 10 May, 2018

Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy

Volume:16   Issue: 5
Pp: 508-518
Marc Fakhoury*
DOI: 10.2174/1570159X15666170720095240
Published on: 19 July, 2017

Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder

Volume:16   Issue: 5
Pp: 519-532
Jairo Vinicius Pinto, Ives Cavalcante Passos, Diego Librenza-Garcia, Grasiela Marcon, Maiko Abel Schneider, Joao Henrique Conte, Joao Pedro Abreu da Silva, Luiza Pereira Lima, Andre Quincozes-Santos, Marcia Kauer-Sant`Anna and Flavio Kapczinski*
DOI: 10.2174/1570159X15666170828170921
Published on: 28 August, 2017

Imaging the Role of Inflammation in Mood and Anxiety-related Disorders

Volume:16   Issue: 5
Pp: 533-558
Jennifer C. Felger*
DOI: 10.2174/1570159X15666171123201142
Published on: 23 November, 2017

The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments

Volume:16   Issue: 5
Pp: 559-573
Yong-Ku Kim and Cheolmin Shin*
DOI: 10.2174/1570159X15666170915141036
Published on: 15 September, 2017

Neuroinflammation and the Immune-Kynurenine Pathway in Anxiety Disorders

Volume:16   Issue: 5
Pp: 574-582
Yong-Ku Kim and Sang Won Jeon*
DOI: 10.2174/1570159X15666170913110426
Published on: 13 September, 2017

Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review

Volume:16   Issue: 5
Pp: 583-606
Laura Orsolini, Fabiola Sarchione, Federica Vellante, Michele Fornaro, Ilaria Matarazzo, Giovanni Martinotti, Alessandro Valchera, Marco Di Nicola, Alessandro Carano, Massimo Di Giannantonio, Giampaolo Perna, Luigi Olivieri and Domenico De Berardis*
DOI: 10.2174/1570159X16666180119144538
Published on: 19 January, 2018

Editorial: The Role of Ca2+-activated K+ Channels of Intermediate Conductance in Glioblastoma Malignancy free to download

Volume:16   Issue: 5
Pp: 607-607
Luigi Catacuzzeno and Fabio Franciolini
DOI: 10.2174/1570159X1605180510154222
Published on: 10 May, 2018

Structure, Gating and Basic Functions of the Ca2+-activated K Channel of Intermediate Conductance

Volume:16   Issue: 5
Pp: 608-617
Luigi Sforna, Alfredo Megaro, Mauro Pessia, Fabio Franciolini* and Luigi Catacuzzeno*
DOI: 10.2174/1570159X15666170830122402
Published on: 30 August, 2017

KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma

Volume:16   Issue: 5
Pp: 618-626
Brandon M. Brown, Brandon Pressley and Heike Wulff*
DOI: 10.2174/1570159X15666170630164226
Published on: 30 June, 2017

KCa3.1 Channels and Glioblastoma: In Vitro Studies

Volume:16   Issue: 5
Pp: 627-635
Lukas Klumpp, Efe C. Sezgin, Marco Skardelly, Franziska Eckert and Stephan M. Huber*
DOI: 10.2174/1570159X15666170808115821
Published on: 08 August, 2017

Functional Roles of the Ca2+-activated K+ Channel, KCa3.1, in Brain Tumors

Volume:16   Issue: 5
Pp: 636-643
Giuseppina D`Alessandro, Cristina Limatola* and Myriam Catalano
DOI: 10.2174/0929867324666170713103621
Published on: 12 July, 2017